CSPC Pharmaceutical Group has entered into a contract with AstraZeneca in relation to the establishment of a joint ...
AuctuCel, a Singapore-based biotechnology company specialising in AI-powered bioprocess technologies, has announced the ...
BIOSPECTRUM ASIA | EARNINGS ALERTS +35.2% 10.7 pt -15% EUR 0.15 Celltrion r...
Northwest Biotherapeutics, a US-based biotechnology company developing DCVax® personalised immune therapies for soli...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is collaborating with Hilleman Laboratories, a Singa...
Moderna, Inc. has announced that the US Food and Drug Administration (FDA) has approved mFLUSIVA® (mRNA-1010), a new...
Energenesis Biomedical has entered into a joint development agreement with Taiwan Tanabe Seiyaku, the wholly owned ...
For decades, cancer treatment has largely focused on finding a single breakthrough therapy capable o...
Alteogen Inc., a South Korea-based biopharmaceutical company specialising in platform technologies, has entered into an ...
On 29 September, the second compliance date under Proclamation 11020 arrives. From that moment, every pharmaceutical imp...
AsymBio, a China-based biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of ...
South Korea-based Ainex Corporation, a medical AI company specialising in gastrointestinal endoscopy, has signed an agre...
Fujifilm Corporation and Taiho Pharmaceutical have entered into a strategic partnership agreement for the development of...
CREATE Medicines, Inc., a US-based clinical-stage biotechnology company pioneering in vivo immune programming, has annou...
RESILIA tissue has been positioned as a significant advancement in valve technology. How does RESILIA tissue differ from...
Bispecific antibodies have transformed treatment by simultaneously targeting two molecules, delivering significant clini...
Although each rare disease affects only a small number of people, collectively they represent one of the world's largest...
Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discover...
Amorepacific Holdings has signed a strategic investment agreement with Korean startup HIGHER Corporation, a medical aest...
Ember LifeSciences, Inc. has entered into a capital and business alliance with Alfresa Corporation, a subsidiary of Alfr...
Japan-based Ono Pharmaceutical and US-based Phylo, Inc. have announced a collaboration that brings Biomni Lab, Phylo's a...
DKSH Business Unit Healthcare, a strategic healthcare solutions partner and leading provider of Market Expansion Service...
Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to...
BioSpectrum Asia launched the APAC Bioeconomy Index 2026, the first independent, region-native benchmark of Asia-Pacific...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
